Guardion Health Sciences, which sells medical food and devices for retinal diseases, raised $5 million by offering 1.25 million shares at $4.
Guardion Health Sciences plans to list on the NYSE under the symbol GHSI. WallachBeth Capital and WestPark Capital acted as lead managers on the deal.
